Literature DB >> 32484854

Interleukin-15 superagonist (N-803) treatment of PML and JCV in a post-allogeneic hematopoietic stem cell transplant patient.

Aabha Oza1, Michael P Rettig1, Phil Powell1, Kathryn O'Brien1, David B Clifford2, Julie Ritchey1, Leah Gehrs1, Julia Hollaway1, Eugene Major3, Todd A Fehniger1, Christopher A Miller4, Patrick Soon-Shiong5, Amy Rock5, John F DiPersio1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32484854      PMCID： PMC7284083          DOI： 10.1182/bloodadvances.2019000664

Source DB:  PubMed          Journal:  Blood Adv        ISSN： 2473-9529


× No keyword cloud information.
  36 in total

1.  Sustained recovery of progressive multifocal leukoencephalopathy after treatment with IL-2.

Authors:  Lara Kunschner; Thomas F Scott
Journal:  Neurology       Date:  2005-11-08       Impact factor: 9.910

2.  Association of prolonged survival in HLA-A2+ progressive multifocal leukoencephalopathy patients with a CTL response specific for a commonly recognized JC virus epitope.

Authors:  Igor J Koralnik; Renaud A Du Pasquier; Marcelo J Kuroda; Jörn E Schmitz; Xin Dang; Yue Zheng; Michelle Lifton; Norman L Letvin
Journal:  J Immunol       Date:  2002-01-01       Impact factor: 5.422

3.  Successful treatment of progressive multifocal leukoencephalopathy with low-dose interleukin-2.

Authors:  D Przepiorka; K A Jaeckle; R R Birdwell; G N Fuller; A J Kumar; Y O Huh; I McCutcheon
Journal:  Bone Marrow Transplant       Date:  1997-12       Impact factor: 5.483

4.  OMIP-042: 21-color flow cytometry to comprehensively immunophenotype major lymphocyte and myeloid subsets in human peripheral blood.

Authors:  Karl W Staser; William Eades; Jaebok Choi; Darja Karpova; John F DiPersio
Journal:  Cytometry A       Date:  2017-12-30       Impact factor: 4.355

Review 5.  Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain.

Authors:  Michael W Ferenczy; Leslie J Marshall; Christian D S Nelson; Walter J Atwood; Avindra Nath; Kamel Khalili; Eugene O Major
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

6.  Glycolytic requirement for NK cell cytotoxicity and cytomegalovirus control.

Authors:  Annelise Y Mah; Armin Rashidi; Molly P Keppel; Nermina Saucier; Emily K Moore; Joshua B Alinger; Sandeep K Tripathy; Sandeep K Agarwal; Emily K Jeng; Hing C Wong; Jeffrey S Miller; Todd A Fehniger; Emily M Mace; Anthony R French; Megan A Cooper
Journal:  JCI Insight       Date:  2017-12-07

Review 7.  Progressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome (IRIS).

Authors:  Jan Bauer; Ralf Gold; Ortwin Adams; Hans Lassmann
Journal:  Acta Neuropathol       Date:  2015-09-01       Impact factor: 17.088

8.  In situ evidence of JC virus control by CD8+ T cells in PML-IRIS during HIV infection.

Authors:  Guillaume Martin-Blondel; Jan Bauer; Victor Cuvinciuc; Emmanuelle Uro-Coste; Alexa Debard; Patrice Massip; Marie-Bernadette Delisle; Hans Lassmann; Bruno Marchou; Lennart T Mars; Roland S Liblau
Journal:  Neurology       Date:  2013-08-09       Impact factor: 9.910

9.  Nonmyeloablative allogeneic stem cell transplantation for refractory Hodgkin's lymphoma complicated by interleukin-2 responsive progressive multifocal leukoencephalopathy.

Authors:  R J Buckanovich; G Liu; C Stricker; S M Luger; E A Stadtmauer; S J Schuster; K Duffy; D Tsai; A Pruitt; D L Porter
Journal:  Ann Hematol       Date:  2002-07-12       Impact factor: 3.673

10.  Allogeneic BK Virus-Specific T Cells for Progressive Multifocal Leukoencephalopathy.

Authors:  Muharrem Muftuoglu; Amanda Olson; David Marin; Sairah Ahmed; Victor Mulanovich; Sudhakar Tummala; T Linda Chi; Alessandra Ferrajoli; Indreshpal Kaur; Li Li; Richard Champlin; Elizabeth J Shpall; Katayoun Rezvani
Journal:  N Engl J Med       Date:  2018-10-11       Impact factor: 91.245
View more
  1 in total

Review 1.  Advances in Treatment of Progressive Multifocal Leukoencephalopathy.

Authors:  Raphaël Bernard-Valnet; Igor J Koralnik; Renaud Du Pasquier
Journal:  Ann Neurol       Date:  2021-09-07       Impact factor: 11.274
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.